Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
Clinical trial NCT02996448 · TERMINATED
Trial details
- NCT number
- NCT02996448
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-17
- Primary completion
- 2018-07-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.